(58) synthesized OxPt/DHA nanoparticles, which significantly enhanced the efficacy of ICIs by increasing the uptake of DHA and OxPt precursors by CRC cells and enhancing the infiltration of CD8+ T cells within the tumor. The gene discussed is CD8A; the disease is colorectal carcinoma.